Key result
The MultiCode-PLx PCR assay detected respiratory viruses in 38% of samples compared to 12% by conventional rapid viral culture and DFA staining in patients with hematologic malignancies.
Why the study?
Does the MultiCode-PLx Respiratory Virus Panel improve the detection of respiratory viruses compared to rapid viral culture with DFA in patients with hematologic malignancies?
Observational (n=70)
Does the MultiCode-PLx Respiratory Virus Panel improve the detection of respiratory viruses compared to rapid viral culture with DFA in patients with hematologic malignancies?
The MultiCode-PLx PCR assay significantly increases the diagnostic yield for respiratory viruses in patients with hematologic malignancies compared to conventional rapid viral culture.
Answers are grounded in this paper and cite their sources.
May enhance detection in hematologic malignancy patients; leaves open impact on management and outcomes.
Respiratory viral pathogens are a common cause of morbidity in patients with hematologic malignancies. Sensitive molecular assays have increased the detection of common respiratory viruses and expanded the panel of detectable viruses. Both a rapid viral culture with direct fluorescence antibody (DFA) staining and a PCR-based assay (MultiCode-PLx Respiratory Virus Panel) were performed on patients with hematologic malignancies, who underwent collection of a nasopharyngeal swab or bronchoalveolar lavage from October 2006 to April 2007. Eighty-two samples from 70 patients were obtained; all patients had upper respiratory tract symptoms. Respiratory viruses were detected in 10 samples (12%) by conventional virological methods and in 31 samples (38%) by the MultiCode-PLx assay. This increased diagnostic yield resulted from better sensitivity for those viruses detectable by both methods and detection of viruses not covered by the antigen detection/rapid culture method (human metapneumovirus, coronaviruses and rhinoviruses). The MultiCode-PLx assay frequently identified respiratory viral infections which are not detected by rapid viral culture/DFA; 40% of these patients had pneumonia in addition to the upper respiratory tract symptoms. Improved diagnostics for respiratory viruses may lead to more effective management and better outcomes in this patient population.
No takes yet. Share an insight, caveat, or question.
Murali et al. (2009) conducted an observational in Hematologic malignancies (n=70). MultiCode-PLx Respiratory Virus Panel vs. Rapid viral culture with direct fluorescence antibody (DFA) staining was evaluated on Detection of respiratory viruses. The MultiCode-PLx PCR assay detected respiratory viruses in 38% of samples compared to 12% by conventional rapid viral culture and DFA staining in patients with hematologic malignancies.
Synapse has enriched 10 related papers. Consider them for comparative context: